Non-transferrin bound iron measurement is influenced by chelator concentration

被引:23
作者
Kolb, A. M. [1 ]
Smit, N. P. M. [1 ]
Lentz-Ljuboje, R. [1 ]
Osanto, S. [2 ]
van Pelt, J. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Clin Chem, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands
关键词
Non-transferrin bound iron; Chemotherapy; Colorimetric assay; HPLC; MEDICAL PROGRESS; SERUM; QUANTIFICATION;
D O I
10.1016/j.ab.2008.11.003
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Release of non-protein bound iron plays an important role in the toxicity inflicted by chemotherapy in cancer patients. Since large variations have been described for different methods measuring non-transferrin bound iron (NTBI), we aimed to obtain more accurate values. After binding to the chelator nitrilotriacetic acid disodium salt (NTA) and ultrafiltration, the NTBI can be measured spectrophotometrically by the addition of thioglycolic acid (TGA) and baptophenanthroline disulfonic acid (BPT). Results demonstrated hat NTBI values increased with NTA concentration. In samples incubated with 80 mM NTA, >5-fold higher NTBI values were found compared to using 10 mM NTA. Optimal concentration of NTA was established by additions of iron to serum with known latent iron-binding capacity (LIBC). Iron addition curves showed that NTBI could be measured starting from the LIBC of the serum with optimal yield after incubation with 4 mM NTA in 5 mM Tris-HCl pH 6.5, with 3 mM TGA anti 6.2 mM BPT for the colour reaction. The results showed excellent correlation with 195 samples measured also by HPLC. For the spectrophotometric method, significantly higher NTBI values were measured in patient samples with maximal iron saturation compared to patients with lower iron saturation. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:13 / 19
页数:7
相关论文
共 18 条
  • [11] A simple and rapid method for the determination of "free" iron in biological fluids
    Nilsson, UA
    Bassen, M
    Sävman, K
    Kjellmer, I
    [J]. FREE RADICAL RESEARCH, 2002, 36 (06) : 677 - 684
  • [12] DETERMINATION OF SERUM IRON AND LATENT IRON-BINDING CAPACITY (LIBC)
    PERSIJN, JP
    VANDERSL.W
    RIETHORST, A
    [J]. CLINICA CHIMICA ACTA, 1971, 35 (01) : 91 - +
  • [13] Medical progress - Hereditary hemochromatosis - A new look at an old disease
    Pietrangelo, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) : 2383 - 2397
  • [14] Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy
    Porter, JB
    Abeysinghe, RD
    Marshall, L
    Hider, RC
    Singh, S
    [J]. BLOOD, 1996, 88 (02) : 705 - 713
  • [15] A DIRECT METHOD FOR QUANTIFICATION OF NON-TRANSFERRIN-BOUND IRON
    SINGH, S
    HIDER, RC
    PORTER, JB
    [J]. ANALYTICAL BIOCHEMISTRY, 1990, 186 (02) : 320 - 323
  • [16] Non-protein bound iron release during chemotherapy in cancer patients
    Weijl, NI
    Elsendoorn, TJ
    Moison, RMW
    Lentjes, EGWM
    Brand, R
    Berger, HM
    Osanto, S
    [J]. CLINICAL SCIENCE, 2004, 106 (05) : 475 - 484
  • [17] WILLIAMS HL, 1977, CLIN CHEM, V23, P237
  • [18] ZHANG DX, 1995, BIOCHEM MOL BIOL INT, V35, P635